ERBB2 and triple-negative breast carcinoma: Molecular profiling has led to the identification of four intrinsic molecular subtypes; luminal A, luminal B, HER2 + and triple-negative breast cancer (TNBC; ER-/PR-/HER2-) which represent biologically distinct disease entities [3, 4].